Dr. Lawrence Baum, M.D.
What this data tells you about Dr. Baum
Dr. Lawrence Baum is an urology physician in Houston, TX, with 16 years in practice. Based on federal Medicare data, Dr. Baum performed 3,939 Medicare services across 2,362 unique beneficiaries.
Between the years covered by Open Payments, Dr. Baum received a total of $25,807 from 81 pharmaceutical and/or device companies across 784 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 871 | $46 | $65 |
| Automated urinalysis | 676 | $2 | $2 |
| Office visit, established patient (30-39 min) | 579 | $90 | $137 |
| Office visit, established patient (20-29 min) | 333 | $61 | $97 |
| Hospital follow-up visit, high complexity | 200 | $94 | $123 |
| Hospital follow-up visit, moderate complexity | 158 | $63 | $82 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 140 | $132 | $181 |
| Blood draw (venipuncture) | 132 | $8 | $9 |
| Bladder ultrasound after voiding | 131 | $7 | $11 |
| New patient office visit (45-59 min) | 123 | $108 | $180 |
| New patient office visit (30-44 min) | 88 | $77 | $116 |
| Ceftriaxone antibiotic injection | 65 | $0 | $1 |
| Initial hospital admission, moderate complexity | 52 | $104 | $134 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 45 | $23 | $35 |
| Ultrasound scan of pelvic region through rectum | 41 | $24 | $39 |
| Diagnostic exam of bladder and urethra using an endoscope | 32 | $182 | $257 |
| Biopsy of prostate gland | 30 | $91 | $259 |
| Drug injection, under skin or into muscle | 28 | $10 | $22 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 27 | $66 | $86 |
| Office visit, established patient, complex (40-54 min) | 21 | $139 | $184 |
| Insertion of temporary bladder tube | 20 | $34 | $53 |
| Insertion of stent in ureter using an endoscope | 17 | $102 | $429 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $315 | $425 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 16 | $550 | $1,679 |
| Simple insertion of temporary bladder tube | 15 | $44 | $64 |
| Injection of biodegradable material next to prostate | 15 | $2,406 | $2,999 |
| 3d radiographic procedure with computerized image postprocessing | 15 | $29 | $39 |
| Placement of device in prostate for radiation therapy | 14 | $63 | $157 |
| Ultrasonic guidance for needle placement | 14 | $48 | $60 |
| Tissue marker, implantable, any type, each | 14 | $68 | $200 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 11 | $5 | $8 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for urology physician in TX.
Geographic Context
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Baum is a clinical cardiology specialist, with above-average Medicare volume (top 30% in TX), and high industry engagement (low-engagement, top 10%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Baum experienced with chronic care management, first 20 min/month?
Does Dr. Baum receive payments from pharmaceutical companies?
How do Dr. Baum's costs compare to other urology physicians in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology